IGC Pharma News

IGC Pharma | S-3: Registration statement for specified transactions by certain issuers

Apr 18 13:17 ET

IGC Pharma | 8-K: Current report

Apr 5 11:38 ET

IGC Pharma | 8-K: Current report

Mar 28 13:07 ET

IGC Pharma | 8-K: Current report

Mar 22 13:14 ET

IGC Pharma | 424B5: Prospectus

Mar 22 13:14 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Officer MUKUNDA RAM

Mar 18 15:55 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director GRIMALDI CLAUDIA

Mar 15 21:32 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director PRINS RICHARD K

Mar 15 21:12 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director Moran James P

Mar 15 21:07 ET

IGC Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 15 20:37 ET

IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director LIERMAN TERRY L

Mar 15 17:37 ET

IGC Pharma | 8-K: Current report

Mar 13 09:03 ET

IGC Pharma | 3: Initial statement of beneficial ownership of securities-Director LIERMAN TERRY L

Mar 12 17:13 ET

IGC Pharma | 10-Q: Quarterly report

Feb 14 18:00 ET

IGC Pharma | 424B5: Prospectus

Jan 31 16:09 ET

IGC Pharma | EFFECT: Others

Jan 9 00:00 ET

IGC Pharma | UPLOAD: Others

Jan 4 12:13 ET

IGC Pharma | CORRESP: CORRESP

Jan 4 12:13 ET

IGC Pharma | S-3: Registration statement for specified transactions by certain issuers

Dec 29, 2023 00:00 ET

IGC Pharma: Q2 2024 Earnings Report

Nov 9, 2023 17:15 ET